Sort
141,003 grants matching “cytokine”
Engineering the Next Generation of T Cells
$6,668,121Carl H. June · University Of Pennsylvania · U54 · FY2019 · CA
Epigenetic events underlying Type I diabetes
$6,608,013Angela M Christiano · Columbia University Health Sciences · DP3 · FY2011 · DK
DARE: Delaney AIDS Research Enterprise to find a cure.
$6,511,956Steven Grant Deeks · University Of California, San Francisco · U19 · FY2012 · AI
HIV/AIDS Vaccine Development
$6,479,016John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
HIV/AIDS Vaccine Development
$6,479,015Gary J Nabel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
HIV/AIDS Vaccine Development
$6,479,015John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Genetics, Pathophysiology, and Treatment of Autoinflammatory and Autoimmune Diseases
$6,465,304Daniel Kastner · National Human Genome Research Institute · ZIA · FY2025 · HG
DCTD Biopharmaceutical Development
$6,449,441David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2016 · CA
Characterization, optimization, and development of dual mGlu2/3 positive allosteric modulators for opioid use disorder
$6,445,203Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · DA
Impact of maternal substance use on offspring neurobehavioral development
$6,439,263Andrea Goldberg Edlow · Massachusetts General Hospital · R01 · FY2023 · HD
Preventive Vaccines for HIV
$6,398,923Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
DCTD Biopharmaceutical Development
$6,373,511David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2015 · CA
NIAAA Repository/Screening Database Management and Research
$6,351,050Melanie Schwandt · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2025 · AA
Clinical Core
$6,233,431Ziad Nahas · University Of Minnesota · U54 · FY2023 · AT
Alliance for Cellular Signaling
$6,164,375University Of Texas Sw Med Ctr/Dallas · U54 · FY2005 · GM
Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral Sclerosis
$6,151,947James Dale Berry · Massachusetts General Hospital · U01 · FY2025 · NS
REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD
$6,107,805E Wesley Ely · Vanderbilt University Medical Center · R01 · FY2025 · AG
STATISITICAL DESIGN, MONITORING & COORD. OF VISION CLINICAL TRIALS & EPIDEMIOLOGY
$6,064,830Keri, Hammel · The Emmes Company, Llc · N01 · FY2013 · EY
STATISITICAL DESIGN, MONITORING & COORD. OF VISION CLINICAL TRIALS & EPIDEMIOLOGY
$6,059,050Keri Hammel · The Emmes Company, Llc · N01 · FY2014 · EY
Overall Atopic Dermatitis Research Network
$6,000,000Donald Ym Leung · National Jewish Health · U19 · FY2017 · AI
Overall Atopic Dermatitis Research Network
$5,999,999Donald Ym Leung · National Jewish Health · U19 · FY2015 · AI
Translational Immunology Core
$5,972,985Lisa Wagar · University Of California-Irvine · U19 · FY2024 · AI
Transfusion Medicine/Hemostasis Clinical Trials Network-Data Coordinating Center
$5,939,962Susan Fera Assmann · New England Research Institutes, Inc. · U01 · FY2011 · HL
Overall Atopic Dermatitis Research Network
$5,920,878Donald Ym Leung · National Jewish Health · U19 · FY2018 · AI
Lifecourse Approach to Developmental Repercussions of Environmental Agents on Metabolic and Respiratory health (LA DREAMERs)
$5,902,614Frank D. Gilliland · University Of Southern California · UH3 · FY2019 · OD